Boston University School of Medicine Reaserchers Awarded Citation From Boston City Council
Contact: Allison Rubin, 617-638-8491 | firstname.lastname@example.org
(Boston)- Boston University School of Medicine (BUSM) researchers Robert C. Green, MD, MPH, and Robert A. Stern, PhD, will be awarded a citation from At-Large City Councillor, Michael F. Flaherty for their contributions to the fight against Alzheimer’s disease. The presentation will be held at Boston City Hall on Wednesday, November 28, 2007 at 11:15 a.m. Drs. Green and Stern are co-directors of BUSM’s Alzheimer’s Disease Clinical and Research program (ADCRP).
“On behalf of all Boston residents touched by Alzheimer’s disease, I commend Drs. Green and Stern for their leadership and commitment to the field of Alzheimer’s research. I am proud to formally recognize their significant and expansive contributions to understanding the many aspects of this devastating neurological disorder,” said Michael F. Flaherty, At-Large Boston City Councillor.
Green and Stern’s program conducts clinical research into the risk factors, genetics, prevention and diagnosis of Alzheimer’s disease, as well as issues pertaining to dementia caregivers. The ADCRP serves as a major site for national clinical trials of treatments for Alzheimer’s disease, including the newest investigational medications aimed at modifying the course of the disease. In addition, the program provides clinical evaluations and treatment for individuals with memory loss and dementia.
ADCRP research is funded by the National Institutes of Health, foundations, industry and philanthropic contributions. The program is also the home of the clinical research arm of the BU Alzheimer’s Disease Center (ADC), one of 30 such centers around the country funded by the National Institute on Aging. The three primary missions of the Center are to conduct and facilitate cutting-edge Alzheimer’s disease research, to enhance clinical care for Alzheimer’s disease patients and their families and to provide education regarding Alzheimer’s disease to both professional and lay audiences in the greater Boston area and beyond.
Green and Stern were recently featured in a documentary entitled: Improving the lives of patients and families with Alzheimer’s disease. The documentary was produced by Information Television Network, and aired on PBS stations nationwide during the month of November which is National Alzheimer’s Disease Awareness Month. Currently, there are over 5 million Americans with Alzheimer’s disease, with the number expected to grow to 16 million by 2050. Alzheimer’s is a degenerative brain disease that is the most common cause of dementia. Alzheimer’s destroys brain cells, causing problems with memory, thinking and behavior severe enough to affect work, hobbies or social life. It is a progressive disease and is ultimately fatal. Today it is the seventh-leading cause of death in the United States. Earlier this year, Drs. Green and Stern were invited to Washington, DC by Congressman Edward Markey (D-MA) to brief the Bipartisan Congressional Task Force on Alzheimer’s Disease.
Green is a professor in neurology, genetics and epidemiology at BUSM. Stern is an associate professor of neurology at BUSM.
For more information on the Boston University Alzheimer’s Disease Clinical and Research Program and the Alzheimer’s Disease Center, please visit